Ready to secure non-dilutive funding to take your startup to the next level?
Join Kirk Macolini, President of InteliSpark, LLC, for this virtual workshop providing insights into the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) application process. During the workshop, Macolini will discuss and answer questions regarding writing and submitting a successful SBIR/STTR proposal and identifying strategies for making your SBIR/STTR proposal more competitive.
Upon registering, participants will receive access to the SBIR/STTR video series, a set of short videos containing valuable background information, which they are encouraged to view prior to the workshop. The pre-workshop video series covers:
Are you a STEM researcher interested in making an impact with your technology innovation? The National Science Foundation’s I-Corps program can provide you with professional training, mentoring, and up to $50,000 in funding for customer discovery.
Hosted by the Interior Northeast I-Corps Hub (IN I-Corps), the virtual NSF I-Corps Information Session is designed for busy graduate students, postdocs and faculty interested in learning more about I-Corps regional and national programming. NSF I-Corps instructor Ken Rother will be joined by Hunter Adams, a new instructor and program alum, to share their experience and answer questions.
The NSF created I-Corps (Innovation Corps) to bridge the gap between fundamental research discoveries in science and engineering and the commercialization of technologies, products and processes with the potential to benefit society.
This is the third installment in Osage University Partners’ series on Funding and Equity for University Startups. Marc Singer and Matt Cohen of OUP will review Valuation and Term Sheets:
How valuation works
Valuation scenarios
How OUP does comp analyses for companies
Basics of a startup investment term sheet
How term sheet negotiations work
Finalizing the term sheet and the financing of the company
The intended audience for this webinar is university startup founders, including future founders and academic technology commercialization groups. You may submit your questions ahead of time on the registration page or by emailing kmangels@oup.vc.
This exciting program is for Principal Investigators who are employed full-time by Weill Cornell Medicine. Tri-I TDI partners with Takeda Pharmaceuticals to advance early-stage projects, that have the potential to benefit patients, to proof-of-concept studies.
The program’s objective is to develop novel compounds that elucidate fundamental physiologic and pathological processes, improve efficiency in drug development, create intellectual property that can be further developed by industry collaborators, and translate basic research into clinical application.
Only small molecule chemical compounds will be considered, which excludes antibody, protein and any other biologic therapeutics.
